Department of Cancer Biology and Genetics, Ohio State University College of Medicine, Columbus, OH, United States of America.
Center for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, MD, United States of America; Department of Neurobiology, University of Maryland School of Medicine, Baltimore, MD, United States of America.
Neurobiol Dis. 2024 Oct 15;201:106674. doi: 10.1016/j.nbd.2024.106674. Epub 2024 Sep 18.
Mutations in UBQLN2 cause ALS and frontotemporal dementia (FTD). The pathological signature in UBQLN2 cases is deposition of highly unusual types of inclusions in the brain and spinal cord that stain positive for UBQLN2. However, what role these inclusions play in pathogenesis remains unclear. Here we show cellular prion protein (PrP) is found in UBQLN2 inclusions in both mouse and human neuronal induced pluripotent (IPSC) models of UBQLN2 mutations, evidenced by the presence of aggregated forms of PrP with UBQLN2 inclusions. Turnover studies indicated that the P497H UBQLN2 mutation slows PrP protein degradation and leads to mislocalization of PrP in the cytoplasm. Immunoprecipitation studies indicated UBQLN2 and PrP bind together in a complex. The abnormalities in PrP caused by UBQLN2 mutations may be relevant in disease pathogenesis.
UBQLN2 突变可导致肌萎缩侧索硬化症(ALS)和额颞叶痴呆(FTD)。UBQLN2 病例的病理学特征是大脑和脊髓中沉积了高度异常的包涵体,这些包涵体对 UBQLN2 呈阳性染色。然而,这些包涵体在发病机制中扮演什么角色仍不清楚。在这里,我们发现在 UBQLN2 突变的小鼠和人类神经元诱导多能干细胞(iPSC)模型中,细胞朊病毒蛋白(PrP)存在于 UBQLN2 包涵体中,这一点可通过存在与 UBQLN2 包涵体共定位的聚集形式的 PrP 来证明。周转率研究表明,P497H UBQLN2 突变可减缓 PrP 蛋白的降解,并导致 PrP 在细胞质中的定位错误。免疫沉淀研究表明 UBQLN2 和 PrP 结合在一起形成复合物。UBQLN2 突变引起的 PrP 异常可能与疾病发病机制有关。